| |
| |
|
| Insider
Information: |
Loewy Caroline M |
| Relationship: |
Director |
| City: |
Seattle |
| State: |
WA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
4 |
|
| Direct
Shares |
18,625 |
|
|
Indirect Shares
|
30,000 |
|
|
| Direct
Value |
$0 |
|
|
|
Indirect Value
|
$3 |
|
|
| Total
Shares |
48,625 |
|
|
| Total
Value |
$3 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Poniard Pharmaceuticals |
PARD |
CFO |
2008-03-04 |
0 |
2008-03-06 |
30,000 |
Premium* |
|
|
Phasebio Pharmaceuticals Inc |
PHAS |
Director |
2023-05-19 |
3,750 |
2023-05-19 |
0 |
Premium* |
|
|
Effector Therapeutics Ord Shs |
EFTR |
Director |
2023-09-09 |
9,047 |
|
0 |
Premium* |
|
|
Phoenix Biotech Acquisition Corp. |
PBAX |
Director |
2024-02-14 |
5,828 |
2024-02-14 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
6 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| PBAX |
Phoenix Biotech Acquisiti... |
Director |
– • – |
2024-02-14 |
4 |
A |
$0.00 |
$0 |
D/D |
5,828 |
5,828 |
0 |
- |
|
| EFTR |
Effector Therapeutics Ord... |
Director |
– • – |
2023-09-09 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
9,047 |
|
- |
|
| PHAS |
Phasebio Pharmaceuticals ... |
Director |
– • – |
2023-05-19 |
4 |
OE |
$0.00 |
$0 |
D/D |
3,750 |
3,750 |
0 |
- |
|
| PARD |
Poniard Pharmaceuticals |
CFO |
• – – |
2008-03-06 |
4 |
B |
$3.92 |
$6,276 |
I/I |
1,600 |
30,000 |
1.99 |
- |
|
| PARD |
Poniard Pharmaceuticals |
CFO |
• – – |
2008-03-05 |
4 |
B |
$3.65 |
$32,920 |
I/I |
8,800 |
28,400 |
1.99 |
- |
|
| PARD |
Poniard Pharmaceuticals |
CFO |
• – – |
2008-03-04 |
4 |
B |
$3.58 |
$70,599 |
I/I |
19,600 |
19,600 |
1.99 |
- |
|
6 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
